ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Remus Pharmaceuticals Ltd reported revenue from operations of ₹614.1 Cr (+53.4% YoY) and net profit of ₹24.7 Cr (+14.4% YoY) for H1 FY27.
Remus Pharmaceuticals Ltd reported revenue from operations of ₹453.4 Cr (+30.4% YoY) and net profit of ₹24.6 Cr (+19.4% YoY) for H2 FY26.
Remus Pharmaceuticals reported FY26 consolidated revenue of ₹853.63 Crore and PAT of ₹46.17 Crore. The board recommended a final dividend of ₹0.50 per share.